China NT Pharma Group Company Limited (NT Pharma) announced that its latest corporate communication—comprising the Circular dated 10 August 2026 and the Notice of Extraordinary General Meeting—has been published on both the company’s website (www.ntpharma.com) and Hong Kong Exchanges and Clearing’s website (www.hkexnews.hk).

Key points:

• Scope of documents: The “Current Corporate Communication” includes the 10 August 2026 Circular and the accompanying Extraordinary General Meeting (EGM) notice.

• Access channel: NT Pharma strongly recommends shareholders review the bilingual (English and Chinese) documents through the online versions.

• Printed copies: Non-registered shareholders who experience difficulties accessing the electronic files may request hard copies—English, Chinese, or both—free of charge. A completed request form should be returned to Tricor Investor Services Limited, NT Pharma’s Hong Kong branch share registrar, by post (pre-paid envelope provided) or via email (1011-ecom@vistra.com).

• Validity of request: A printed-copy election will apply to all future corporate communications until written notice is given to the branch share registrar or until 31 December 2026, whichever comes first.

• Communication preference: Shareholders holding shares through intermediaries (banks, brokers, custodians, nominees, or HKSCC Nominees Limited) are advised to provide a valid email address to receive electronic notifications of future publications.

• Investor support: Enquiries can be directed to Tricor Investor Services Limited’s hotline at +852 2980 1333, Monday–Friday, 9:00 a.m.–6:00 p.m. (excluding Hong Kong public holidays).

The notification underscores NT Pharma’s ongoing shift toward digital dissemination of shareholder information, aligning with Hong Kong Listing Rules on corporate communications and reducing reliance on printed materials.